» Articles » PMID: 36596919

Role of Necroptosis in Kidney Health and Disease

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2023 Jan 3
PMID 36596919
Authors
Affiliations
Soon will be listed here.
Abstract

Cell death, particularly that of tubule epithelial cells, contributes critically to the pathophysiology of kidney disease. A body of evidence accumulated over the past 15 years has ascribed a central pathophysiological role to a particular form of regulated necrosis, termed necroptosis, to acute tubular necrosis, nephron loss and maladaptive renal fibrogenesis. Unlike apoptosis, which is a non-immunogenic process, necroptosis results in the release of cellular contents and cytokines, which triggers an inflammatory response in neighbouring tissue. This necroinflammatory environment can lead to severe organ dysfunction and cause lasting tissue injury in the kidney. Despite evidence of a link between necroptosis and various kidney diseases, there are no available therapeutic options to target this process. Greater understanding of the molecular mechanisms, triggers and regulators of necroptosis in acute and chronic kidney diseases may identify shortcomings in current approaches to therapeutically target necroptosis regulators and lead to the development of innovative therapeutic approaches.

Citing Articles

Emerging role of PANoptosis in kidney diseases: molecular mechanisms and therapeutic opportunities.

Hou Y, Feng Q, Wei C, Cao F, Liu D, Pan S Apoptosis. 2025; .

PMID: 39833634 DOI: 10.1007/s10495-024-02072-y.


Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic models.

Zhang Y, Pan R, Shou Z, Zhao Y J Nat Med. 2025; 79(2):314-327.

PMID: 39752106 DOI: 10.1007/s11418-024-01863-6.


GLP-1 Receptor Agonists Alleviate Diabetic Kidney Injury via β-Klotho-Mediated Ferroptosis Inhibition.

Tian S, Zhou S, Wu W, Lin Y, Wang T, Sun H Adv Sci (Weinh). 2024; 12(4):e2409781.

PMID: 39630101 PMC: 11775532. DOI: 10.1002/advs.202409781.


Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets.

Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y MedComm (2020). 2024; 5(12):e70024.

PMID: 39619229 PMC: 11604731. DOI: 10.1002/mco2.70024.


Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetes.

Ihara K, Satake E, Wilson P, Krolewski B, Kobayashi H, Md Dom Z JCI Insight. 2024; 9(20).

PMID: 39435665 PMC: 11529980. DOI: 10.1172/jci.insight.178373.


References
1.
Muller T, Dewitz C, Schmitz J, Schroder A, Brasen J, Stockwell B . Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure. Cell Mol Life Sci. 2017; 74(19):3631-3645. PMC: 5589788. DOI: 10.1007/s00018-017-2547-4. View

2.
Bedoui S, Herold M, Strasser A . Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020; 21(11):678-695. DOI: 10.1038/s41580-020-0270-8. View

3.
Kearney C, Martin S . An Inflammatory Perspective on Necroptosis. Mol Cell. 2017; 65(6):965-973. DOI: 10.1016/j.molcel.2017.02.024. View

4.
Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S . Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2001; 1(6):489-95. DOI: 10.1038/82732. View

5.
Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N . Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2006; 1(2):112-9. DOI: 10.1038/nchembio711. View